Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

INTERACTING NON-SPECIFIC IMMUNOLOGICAL EFFECTS OF BCG AND Tdapf VACCINATIONS: AN EXPLORATIVE RANDOMIZED TRIAL.

Blok BA, de Bree LCJ, Diavatopoulos DA, Langereis JD, Joosten LAB, Aaby P, van Crevel R, Benn CS, Netea MG.

Clin Infect Dis. 2019 Mar 28. pii: ciz246. doi: 10.1093/cid/ciz246. [Epub ahead of print]

PMID:
30919883
2.

Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunity.

Blok BA, Jensen KJ, Aaby P, Fomsgaard A, van Crevel R, Benn CS, Netea MG.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):449-456. doi: 10.1007/s10096-018-03449-z. Epub 2019 Feb 5.

PMID:
30719592
3.

Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine Scar.

Berendsen MLT, Øland CB, Bles P, Jensen AKG, Kofoed PE, Whittle H, De Bree C, Netea MG, Martins C, Benn CS, Aaby P.

J Pediatric Infect Dis Soc. 2019 Feb 3. doi: 10.1093/jpids/piy142. [Epub ahead of print]

PMID:
30715451
4.

Is the decline in neonatal mortality in northern Ghana, 1996-2012, associated with the decline in the age of BCG vaccination? An ecological study.

Welaga P, Debpuur C, Aaby P, Hodgson A, Azongo DK, Benn CS, Oduro AR.

BMJ Open. 2018 Dec 14;8(12):e023752. doi: 10.1136/bmjopen-2018-023752.

5.

How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.

Pedersen KB, Holck ME, Jensen AKG, Suppli CH, Benn CS, Krause TG, Sørup S.

Scand J Public Health. 2018 Jul 1:1403494818786146. doi: 10.1177/1403494818786146. [Epub ahead of print]

PMID:
30024308
6.

Revaccination With Measles-Mumps-Rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.

Sørup S, Jensen AKG, Aaby P, Benn CS.

Clin Infect Dis. 2019 Jan 7;68(2):282-290. doi: 10.1093/cid/ciy433.

PMID:
29846533
7.

Evidence of Increase in Mortality After the Introduction of Diphtheria-Tetanus-Pertussis Vaccine to Children Aged 6-35 Months in Guinea-Bissau: A Time for Reflection?

Aaby P, Mogensen SW, Rodrigues A, Benn CS.

Front Public Health. 2018 Mar 19;6:79. doi: 10.3389/fpubh.2018.00079. eCollection 2018.

8.

Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses.

Ugolini M, Gerhard J, Burkert S, Jensen KJ, Georg P, Ebner F, Volkers SM, Thada S, Dietert K, Bauer L, Schäfer A, Helbig ET, Opitz B, Kurth F, Sur S, Dittrich N, Gaddam S, Conrad ML, Benn CS, Blohm U, Gruber AD, Hutloff A, Hartmann S, Boekschoten MV, Müller M, Jungersen G, Schumann RR, Suttorp N, Sander LE.

Nat Immunol. 2018 Apr;19(4):386-396. doi: 10.1038/s41590-018-0068-4. Epub 2018 Mar 19.

PMID:
29556002
9.

BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.

Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, Kumar V, Xavier RJ, Wijmenga C, Joosten LAB, Reusken CBEM, Benn CS, Aaby P, Koopmans MP, Stunnenberg HG, van Crevel R, Netea MG.

Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5. doi: 10.1016/j.chom.2017.12.010.

10.

Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study.

Funch KM, Thysen SM, Rodrigues A, Martins CL, Aaby P, Benn CS, Fisker AB.

Hum Vaccin Immunother. 2018;14(10):2434-2442. doi: 10.1080/21645515.2017.1421879. Epub 2018 Jan 23.

11.

A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.

Fisker AB, Nebie E, Schoeps A, Martins C, Rodrigues A, Zakane A, Kagone M, Byberg S, Thysen SM, Tiendrebeogo J, Coulibaly B, Sankoh O, Becher H, Whittle HC, van der Klis FRM, Benn CS, Sie A, Müller O, Aaby P.

Clin Infect Dis. 2018 May 2;66(10):1573-1580. doi: 10.1093/cid/cix1033.

12.

Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age.

Brønd M, Martins CL, Byberg S, Benn CS, Whittle H, Garly ML, Aaby P, Fisker AB.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):226-233. doi: 10.1093/jpids/pix042.

PMID:
28992261
13.

Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.

Byberg S, Østergaard MD, Rodrigues A, Martins C, Benn CS, Aaby P, Fisker AB.

PLoS One. 2017 May 18;12(5):e0177984. doi: 10.1371/journal.pone.0177984. eCollection 2017.

14.

Beneficial Nonspecific Effects of Oral Polio Vaccine (OPV): Implications for the Cessation of OPV?

Aaby P, Benn CS.

Clin Infect Dis. 2017 Aug 1;65(3):420-421. doi: 10.1093/cid/cix340. No abstract available.

PMID:
28407072
15.

The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment.

Mogensen SW, Andersen A, Rodrigues A, Benn CS, Aaby P.

EBioMedicine. 2017 Mar;17:192-198. doi: 10.1016/j.ebiom.2017.01.041. Epub 2017 Feb 1.

16.

Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.

Aaby P, Andersen A, Martins CL, Fisker AB, Rodrigues A, Whittle HC, Benn CS.

BMJ Open. 2016 Dec 23;6(12):e013335. doi: 10.1136/bmjopen-2016-013335.

17.

Introduction of standard measles vaccination in an urban African community in 1979 and overall child survival: a reanalysis of data from a cohort study.

Mogensen SW, Aaby P, Smedman L, Martins CL, Rodrigues A, Benn CS, Ravn H.

BMJ Open. 2016 Dec 20;6(12):e011317. doi: 10.1136/bmjopen-2016-011317.

18.
19.

Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study.

Sørup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H.

Vaccine. 2016 Dec 7;34(50):6172-6180. doi: 10.1016/j.vaccine.2016.11.005. Epub 2016 Nov 10.

20.

Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial.

Kjærgaard J, Birk NM, Nissen TN, Thøstesen LM, Pihl GT, Benn CS, Jeppesen DL, Pryds O, Kofoed PE, Aaby P, Greisen G, Stensballe LG.

Pediatr Res. 2016 Nov;80(5):681-685. doi: 10.1038/pr.2016.142. Epub 2016 Jul 18.

PMID:
27429204
21.
22.

The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis Vaccine.

Aaby P, Ravn H, Benn CS.

Pediatr Infect Dis J. 2016 Nov;35(11):1247-1257.

PMID:
27753772
23.

Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.

Aaby P, Ravn H, Benn CS, Rodrigues A, Samb B, Ibrahim SA, Libman MD, Whittle HC.

Pediatr Infect Dis J. 2016 Nov;35(11):1232-1241.

PMID:
27753769
24.

Revaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A Review.

Benn CS, Fisker AB, Whittle HC, Aaby P.

EBioMedicine. 2016 Aug;10:312-7. doi: 10.1016/j.ebiom.2016.07.016. Epub 2016 Jul 15. Review.

25.

Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau.

Fisker AB, Biering-Sørensen S, Lund N, Djana Q, Rodrigues A, Martins CL, Benn CS.

Vaccine. 2016 Aug 31;34(38):4551-4557. doi: 10.1016/j.vaccine.2016.07.034. Epub 2016 Jul 27.

26.

RTS,S Malaria Vaccine and Increased Mortality in Girls.

Klein SL, Shann F, Moss WJ, Benn CS, Aaby P.

MBio. 2016 Apr 26;7(2):e00514-16. doi: 10.1128/mBio.00514-16. No abstract available.

27.

Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study.

Sørup S, Stensballe LG, Krause TG, Aaby P, Benn CS, Ravn H.

Open Forum Infect Dis. 2015 Dec 17;3(1):ofv204. doi: 10.1093/ofid/ofv204. eCollection 2016 Jan.

28.

Setting research priorities to improve global newborn health and prevent stillbirths by 2025.

Yoshida S, Martines J, Lawn JE, Wall S, Souza JP, Rudan I, Cousens S; neonatal health research priority setting group, Aaby P, Adam I, Adhikari RK, Ambalavanan N, Arifeen SE, Aryal DR, Asiruddin S, Baqui A, Barros AJ, Benn CS, Bhandari V, Bhatnagar S, Bhattacharya S, Bhutta ZA, Black RE, Blencowe H, Bose C, Brown J, Bührer C, Carlo W, Cecatti JG, Cheung PY, Clark R, Colbourn T, Conde-Agudelo A, Corbett E, Czeizel AE, Das A, Day LT, Deal C, Deorari A, Dilmen U, English M, Engmann C, Esamai F, Fall C, Ferriero DM, Gisore P, Hazir T, Higgins RD, Homer CS, Hoque DE, Irgens L, Islam MT, de Graft-Johnson J, Joshua MA, Keenan W, Khatoon S, Kieler H, Kramer MS, Lackritz EM, Lavender T, Lawintono L, Luhanga R, Marsh D, McMillan D, McNamara PJ, Mol BW, Molyneux E, Mukasa GK, Mutabazi M, Nacul LC, Nakakeeto M, Narayanan I, Olusanya B, Osrin D, Paul V, Poets C, Reddy UM, Santosham M, Sayed R, Schlabritz-Loutsevitch NE, Singhal N, Smith MA, Smith PG, Soofi S, Spong CY, Sultana S, Tshefu A, van Bel F, Gray LV, Waiswa P, Wang W, Williams SL, Wright L, Zaidi A, Zhang Y, Zhong N, Zuniga I, Bahl R.

J Glob Health. 2016 Jun;6(1):010508. doi: 10.7189/jogh.06.010508.

29.

Reduced All-cause Child Mortality After General Measles Vaccination Campaign in Rural Guinea-Bissau.

Fisker AB, Rodrigues A, Martins C, Ravn H, Byberg S, Thysen S, Storgaard L, Pedersen M, Fernandes M, Benn CS, Aaby P.

Pediatr Infect Dis J. 2015 Dec;34(12):1369-76. doi: 10.1097/INF.0000000000000896.

PMID:
26379164
30.

An enigma: why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality.

Benn CS, Aaby P, Arts RJ, Jensen KJ, Netea MG, Fisker AB.

Int J Epidemiol. 2015 Jun;44(3):906-18. doi: 10.1093/ije/dyv117. Epub 2015 Jul 2. Review.

31.

Unusual positive effects from vaccines need to be reported - They represent a resource that could lead to new treatment strategies.

Clarke MS, Benn CS.

Vaccine. 2015 Jun 22;33(28):3162-3. doi: 10.1016/j.vaccine.2015.04.076. Epub 2015 May 1. No abstract available.

PMID:
25939280
32.

Changes in BCG Vaccination Policy Should Consider the Effect on Child Health.

Thysen SM, Aaby P, Benn CS, Fisker AB.

J Infect Dis. 2015 Oct 15;212(8):1341-2. doi: 10.1093/infdis/jiv198. Epub 2015 Mar 27. No abstract available.

PMID:
25821229
33.

Response to: J Mason et al. Vitamin A policies need rethinking.

Benn CS, Fisker AB, Aaby P.

Int J Epidemiol. 2015 Feb;44(1):366-7. doi: 10.1093/ije/dyu279. Epub 2015 Jan 23. No abstract available.

PMID:
25617648
34.

Sex-differential and non-specific effects of routine vaccinations in a rural area with low vaccination coverage: an observational study from Senegal.

Aaby P, Nielsen J, Benn CS, Trape JF.

Trans R Soc Trop Med Hyg. 2015 Jan;109(1):77-84. doi: 10.1093/trstmh/tru186.

PMID:
25573112
35.

Is early measles vaccination better than later measles vaccination?

Aaby P, Martins CL, Ravn H, Rodrigues A, Whittle HC, Benn CS.

Trans R Soc Trop Med Hyg. 2015 Jan;109(1):16-28. doi: 10.1093/trstmh/tru174. Review.

36.

High-dose vitamin A with vaccination after 6 months of age: a randomized trial.

Fisker AB, Bale C, Rodrigues A, Balde I, Fernandes M, Jørgensen MJ, Danneskiold-Samsøe N, Hornshøj L, Rasmussen J, Christensen ED, Bibby BM, Aaby P, Benn CS.

Pediatrics. 2014 Sep;134(3):e739-48. doi: 10.1542/peds.2014-0550.

37.

Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau.

Benn CS, Martins CL, Fisker AB, Diness BR, Garly ML, Balde I, Rodrigues A, Whittle H, Aaby P.

Vaccine. 2014 Sep 22;32(42):5468-74. doi: 10.1016/j.vaccine.2014.07.090. Epub 2014 Aug 13.

38.

Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.

Fisker AB, Hornshøj L, Rodrigues A, Balde I, Fernandes M, Benn CS, Aaby P.

Lancet Glob Health. 2014 Aug;2(8):e478-87. doi: 10.1016/S2214-109X(14)70274-8. Epub 2014 Jul 23.

39.

Two different doses of supplemental vitamin A did not affect mortality of normal-birth-weight neonates in Guinea-Bissau in a randomized controlled trial.

Benn CS, Diness BR, Balde I, Rodrigues A, Lausch KR, Martins CL, Fisker AB, Aaby P.

J Nutr. 2014 Sep;144(9):1474-9. doi: 10.3945/jn.114.192674. Epub 2014 Jul 2.

PMID:
24991044
40.

Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival.

Aaby P, Martins CL, Garly ML, Andersen A, Fisker AB, Claesson MH, Ravn H, Rodrigues A, Whittle HC, Benn CS.

Clin Infect Dis. 2014 Aug 15;59(4):484-92. doi: 10.1093/cid/ciu354. Epub 2014 May 14.

41.

Both very low- and very high in vitro cytokine responses were associated with infant death in low-birth-weight children from Guinea Bissau.

Andersen A, Jensen KJ, Erikstrup C, Ravn H, Fisker AB, Lisse IM, Sartono E, Aaby P, Yazdanbakhsh M, Benn CS.

PLoS One. 2014 Apr 8;9(4):e93562. doi: 10.1371/journal.pone.0093562. eCollection 2014.

42.

Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.

Martins C, Garly ML, Bale C, Rodrigues A, Njie-Jobe J, Benn CS, Whittle H, Aaby P.

J Infect Dis. 2014 Sep 1;210(5):693-700. doi: 10.1093/infdis/jiu117. Epub 2014 Mar 31.

PMID:
24688075
43.

Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.

Sørup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H.

JAMA. 2014 Feb 26;311(8):826-35. doi: 10.1001/jama.2014.470.

PMID:
24570246
44.

A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions.

Martins CL, Benn CS, Andersen A, Balé C, Schaltz-Buchholzer F, Do VA, Rodrigues A, Aaby P, Ravn H, Whittle H, Garly ML.

J Infect Dis. 2014 Jun 1;209(11):1731-8. doi: 10.1093/infdis/jit804. Epub 2014 Jan 16.

45.

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.

Martins C, Garly ML, Bale C, Rodrigues A, Benn CS, Whittle H, Aaby P.

Vaccine. 2013 Nov 19;31(48):5766-71. doi: 10.1016/j.vaccine.2013.08.044. Epub 2013 Aug 28.

46.

Risk of metabolic syndrome and diabetes among young twins and singletons in Guinea-Bissau.

Bjerregaard-Andersen M, Hansen L, da Silva LI, Joaquím LC, Hennild DE, Christiansen L, Aaby P, Benn CS, Christensen K, Sodemann M, Jensen DM, Beck-Nielsen H.

Diabetes Care. 2013 Nov;36(11):3549-56. doi: 10.2337/dc12-2653. Epub 2013 Aug 15.

47.

A small jab - a big effect: nonspecific immunomodulation by vaccines.

Benn CS, Netea MG, Selin LK, Aaby P.

Trends Immunol. 2013 Sep;34(9):431-9. doi: 10.1016/j.it.2013.04.004. Epub 2013 May 14. Review.

PMID:
23680130
48.

Leukocyte transcript alterations in West-African girls following a booster vaccination with diphtheria-tetanus-pertussis vaccine.

Ørntoft NW, Thorsen K, Benn CS, Lemvik G, Nanque JR, Aaby P, Østergaard L, Agergaard J.

Scand J Clin Lab Invest. 2013;73(4):349-54. doi: 10.3109/00365513.2013.783229. Epub 2013 May 13.

PMID:
23668887
49.

Censored correlated cytokine concentrations: multivariate Tobit regression using clustered variance estimation.

Andersen A, Benn CS, Jørgensen MJ, Ravn H.

Stat Med. 2013 Jul 20;32(16):2859-74. doi: 10.1002/sim.5696. Epub 2012 Dec 5.

PMID:
23212926
50.

The effect of at-birth vitamin A supplementation on differential leucocyte counts and in vitro cytokine production: an immunological study nested within a randomised trial in Guinea-Bissau.

Jørgensen MJ, Fisker AB, Sartono E, Andersen A, Erikstrup C, Lisse IM, Yazdanbakhsh M, Aaby P, Benn CS.

Br J Nutr. 2013 Feb 14;109(3):467-77. doi: 10.1017/S0007114512001304. Epub 2012 Jul 11.

PMID:
23168172

Supplemental Content

Loading ...
Support Center